NCT04810013View on ClinicalTrials.gov

Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

November 30, 2023

Conditions
Complex Congenital Heart Disease
Interventions
PROCEDURE

non-invasive measurement of cerebral autoregulation

Non-invasive measurement of the cerebral autoregulation in the postoperative period in 80 neonates and infants with complex congenital heart disease undergoing cardiopulmonary bypass surgery. A continuous, moving Pearson's correlation coefficient will be calculated between the arterial pressure and near-infrared spectroscopy signals and displayed continuously during surgery using a laptop computer and the ICM+ software (Cambridge Enterprise).

Trial Locations (1)

72076

Univeristy Children's Hospital, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT04810013 - Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease | Biotech Hunter | Biotech Hunter